[HTML][HTML] Medical treatment of mammary desmoid-type fibromatosis: which benefit?
L Scheer, M Lodi, S Molière, JE Kurtz… - World Journal of Surgical …, 2017 - Springer
Background Breast fibromatosis is a rare disease characterized by monoclonal fibroblast
proliferation. It has no ability to metastasize but has a high local recurrence rate and often …
proliferation. It has no ability to metastasize but has a high local recurrence rate and often …
Medical treatment of mammary desmoid-type fibromatosis: which benefit?
L Scheer, M Lodi, S Molière, JE Kurtz… - World Journal of …, 2017 - europepmc.org
Background Breast fibromatosis is a rare disease characterized by monoclonal fibroblast
proliferation. It has no ability to metastasize but has a high local recurrence rate and often …
proliferation. It has no ability to metastasize but has a high local recurrence rate and often …
Medical treatment of mammary desmoid-type fibromatosis: which benefit?
L Scheer, M Lodi, S Molière, JE Kurtz… - World Journal of Surgical …, 2017 - infona.pl
Background Breast fibromatosis is a rare disease characterized by monoclonal fibroblast
proliferation. It has no ability to metastasize but has a high local recurrence rate and often …
proliferation. It has no ability to metastasize but has a high local recurrence rate and often …
[引用][C] Medical treatment of mammary desmoid-type fibromatosis: which benefit?
L Scheer, M Lodi, S Molière, JE Kurtz… - World Journal of Surgical …, 2017 - cir.nii.ac.jp
Medical treatment of mammary desmoid-type fibromatosis: which benefit? | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ] 詳細へ移動 検索フォ恁啶匾動 論文·デ恁郡 …
CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ] 詳細へ移動 検索フォ恁啶匾動 論文·デ恁郡 …
Medical treatment of mammary desmoid-type fibromatosis: which benefit?
L Scheer, M Lodi, S Molière, JE Kurtz… - World Journal of …, 2017 - search.ebscohost.com
Background: Breast fibromatosis is a rare disease characterized by monoclonal fibroblast
proliferation. It has no ability to metastasize but has a high local recurrence rate and often …
proliferation. It has no ability to metastasize but has a high local recurrence rate and often …
Medical treatment of mammary desmoid-type fibromatosis: which benefit?
L Scheer, M Lodi, S Moliere, JE Kurtz… - World Journal of …, 2017 - search.proquest.com
Background Breast fibromatosis is a rare disease characterized by monoclonal fibroblast
proliferation. It has no ability to metastasize but has a high local recurrence rate and often …
proliferation. It has no ability to metastasize but has a high local recurrence rate and often …
Medical treatment of mammary desmoid-type fibromatosis: which benefit?
L Scheer, M Lodi, S Molière, JE Kurtz… - World Journal of Surgical …, 2017 - hal.science
BACKGROUND: Breast fibromatosis is a rare disease characterized by monoclonal
fibroblast proliferation. It has no ability to metastasize but has a high local recurrence rate …
fibroblast proliferation. It has no ability to metastasize but has a high local recurrence rate …
[HTML][HTML] Medical treatment of mammary desmoid-type fibromatosis: which benefit?
L Scheer, M Lodi, S Molière, JE Kurtz… - World Journal of …, 2017 - ncbi.nlm.nih.gov
Background Breast fibromatosis is a rare disease characterized by monoclonal fibroblast
proliferation. It has no ability to metastasize but has a high local recurrence rate and often …
proliferation. It has no ability to metastasize but has a high local recurrence rate and often …
Medical treatment of mammary desmoid-type fibromatosis: which benefit?
L Scheer, M Lodi, S Molière… - World journal of …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Breast fibromatosis is a rare disease characterized by monoclonal fibroblast
proliferation. It has no ability to metastasize but has a high local recurrence rate and often …
proliferation. It has no ability to metastasize but has a high local recurrence rate and often …
[HTML][HTML] Medical treatment of mammary desmoid-type fibromatosis: which benefit?
L Scheer, M Lodi, S Molière… - World Journal of …, 2017 - wjso.biomedcentral.com
Breast fibromatosis is a rare disease characterized by monoclonal fibroblast proliferation. It
has no ability to metastasize but has a high local recurrence rate and often infiltrates …
has no ability to metastasize but has a high local recurrence rate and often infiltrates …
